Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
Stock Information for Altamira Therapeutics Ltd.
Loading
Please wait while we load your information from QuoteMedia.